Morgan Stanley Molecular Partners Ag Call Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MOLN
# of Institutions
7Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$7.95 Million0.38% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$4.85 Million0.23% of portfolio
-
Ubs Group Ag6.35KShares$22,7360.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$9630.0% of portfolio
-
Bank Of America Corp Charlotte, NC157Shares$5620.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $116M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...